Duration: August 2023 to April 2024
Team: Kaitlin Thaney, Katherine Skinner, Sarah Lang
Funder: Cold Spring Harbor Laboratory
Skillset: Business Development Advisory, Fiscal Assessment & Planning, Fundraising Design, Governance Model Development
Overview
bioRxiv and medRxiv serve researchers across virtually every corner of biology and medicine. During the COVID-19 pandemic, medRxiv became one of the primary places the global scientific community turned to share findings in real time. That kind of reach takes infrastructure, and infrastructure takes sustained funding.
For a decade, the servers were supported primarily by Cold Spring Harbor Laboratory and, for a significant stretch, by funding from the Chan Zuckerberg Initiative. That support was essential and it worked. But as the platforms grew, so did the cost of running them, and depending heavily on a small number of funders started to look like a structural risk rather than a stable model.
Cold Spring Harbor Laboratory turned to IOI to guide the bioRxiv and medRxiv teams in developing a more diversified, sustainable funding strategy.
What we did
We started with a thorough needs assessment, mapping what the servers currently relied on financially, where the pressure points were, and what the realistic options for diversification looked like given the platforms' scale, mission, and stakeholder base.
From there, we worked alongside the bioRxiv and medRxiv, leadership to develop a funding diversification strategy. That included identifying which categories of funders and institutions were their most credible targets, articulating the platform’s value in terms that would resonate beyond the existing supporter base, and building a practical approach for outreach that the team could actually execute.
We also worked with the team on the organizational questions that sit underneath funding strategy but tend to shape it. How the technical workflows are designed, how decisions get made, and how stakeholder communities are engaged all affect whether diversified funding is achievable and whether it holds once it arrives.
Outcomes and impact
This collaboration gave the bioRxiv and medRxiv teams a clearer, more structured basis for their funding conversations. Early outreach drew support from institutions including Stanford, MIT, Caltech, the Fred Hutchinson Cancer Center, and several major European research universities, alongside a significant gift from the Sergey Brin Family Foundation.
As John Inglis and Richard Sever, who lead bioRxiv and medRxiv, put it: "IOI is unique in the breadth of its experience and the domain expertise of its executive team. They also have a remarkable range of connections among funding organizations. The needs assessment IOI did on behalf of bioRxiv and medRxiv was very important in helping us set new strategies for diversifying our financial support."
The work also surfaced something that often gets treated as a separate question: governance. As the platforms grow and bring in a wider user base, having clear structures for how those stakeholders participate and how decisions get made becomes an important part of the value proposition.
Following IOI’s work on strategy diversification with bioRxiv and medRxiv, the organisations formed a new independent, nonprofit organisation called OpenRxiv that serves as the organizational home and governing body for bioRxiv and medRxiv
When growth becomes a pressure point
The platforms that researchers depend on most often have funding models that were built for earlier, smaller versions of themselves.
Diversifying financial support is not just a fundraising exercise. It involves understanding your stakeholder landscape, making a compelling case to a broader set of funders, and often revisiting how your organization is structured to support that growth. If your infrastructure is navigating that shift, we can help! Get in touch to talk through what that work might look like.
— John Inglis and Richard Sever, bioRxiv & medRxiv
